The global ethyl linalool market size was USD 1.59 billion in 2023, calculated at USD 1.65 billion in 2024 and is expected to be worth around USD 2.34 billion by 2034. The market is slated to expand at 3.56% CAGR from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Ethyl Linalool Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Ethyl Linalool Market Revenue and Volume Forecast, by Type, 2024-2034
8.1.1. Synthetic
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Natural
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Ethyl Linalool Market Revenue and Volume Forecast, by Molecular Structure, 2024-2034
9.1.1. (R)-Linalool
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. (S)-Linalool
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Racemic Linalool
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Ethyl Linalool Market Revenue and Volume Forecast, by Distribution Channel, 2024-2034
10.1.1. Online Retail
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Direct Sales
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1. Ethyl Linalool Market Revenue and Volume Forecast, by End-user Industry, 2024-2034
11.1.1. Cosmetics
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Food & Beverages
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Personal Care
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1.4. Household Care
11.1.4.1. Market Revenue and Volume Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Molecular Structure (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by End-user Industry (2021-2034)
13.1. Givaudan
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Firmenich
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. IF
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Mane
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Takasago
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Robertet
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sensient Technologies
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bell Flavors & Fragrances
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vigon International
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Advanced Biotech
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client